Piribo: Four Year Forecast of the Allergy Drug Industry available in New Report

June 23, 2009 - PRLog -- Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report that provides important guidance to the allergy drug market.

The report “Allergy Drug Pipeline and R&D 2009: Emerging Technologies, Companies, Products, Applications, Sales & Market Share, and Worldwide Outlook”, available at http://tinyurl.com/mfohmu describes and assesses the current global research initiatives in the field of allergies. It focuses on the most common allergies, such as seasonal and perennial allergic rhinitis and food allergies, which affect more than 300 million persons worldwide.

The 126-page report provides sales estimates from 2008 to 2013  for the leading prescription allergy drugs and vaccines, as well as over-the-counter (OTC) allergy medicines in the U.S., European Union, Japan and rest of world area. Forecasts include an analysis of the market forces affecting sales in each region, as well as a discussion of patent expirations of leading medications and the effects of generic competition on existing allergy drug sales.

Allergy medications and vaccines under development are evaluated with a comprehensive analysis of technology, stage of development and commercialisation potential. This includes new molecular entities and indication expansions of medicines currently approved for other uses. For leading allergy drug candidates, sales estimates from 2009 to 2013 are provided. Profiles of the 12 leading allergy drug developers offer details of these companies' capabilities, particularly focusing on R&D strength, pipeline products, strategic alliances and partnerships, and the effects of any recent merger or acquisition activity. Furthermore, a directory of more than five dozen leading players worldwide allows readers to access companies' own web sites for further review.

Information for this report was gathered from a wide variety of published sources; interviews with company representatives were then conducted to assess trends, and form the basis of the forecasting and competitive analysis. The report is designed for business development and other senior executives, marketers, R&D managers, investors, VCs, consultants, entrepreneurs and others who require an in-depth understanding of the current status of the allergy therapeutics market and potential new products.

“Allergy Drug Pipeline and R&D 2009: Emerging Technologies, Companies, Products, Applications, Sales & Market Share, and Worldwide Outlook” is available from Piribo. For further information, please visit:  
http://www.piribo.com/publications/diseases_conditions/al...

Piribo product ID: FUJ00054

# # #

About Piribo.
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 12,000 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.